⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SLS News
SELLAS Life Sciences Group, Inc. Common Stock
Form 8-K
sec.gov
SLS
SELLAS Life Sciences to Participate in Upcoming Investor Conferences
globenewswire.com
SLS
Form 8-K
sec.gov
SLS
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
SLS
Form 8-K
sec.gov
SLS
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
SLS
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
globenewswire.com
SLS
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
globenewswire.com
SLS
Form 8-K
sec.gov
SLS
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
globenewswire.com
ONCY
SLS
CELC
RNXT